The Nutshell

» funding and disease/medicine

Daily News Roundup

Most Recent

image: British Health Open for Research

British Health Open for Research

By | September 12, 2012

Giving researchers access to the health records of 52 million people in England could prove invaluable to biomedical scientists.

1 Comment

image: Double-Edged TB Drug

Double-Edged TB Drug

By | September 12, 2012

A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.

2 Comments

image: Lasker Winners Announced

Lasker Winners Announced

By | September 10, 2012

This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: UK Ponies Up for Open Access

UK Ponies Up for Open Access

By | September 10, 2012

The United Kingdom government has devoted £10 million towards the goal of making all of the research it funds open access by next spring.

2 Comments

image: The NSF Shake-Up

The NSF Shake-Up

By | September 7, 2012

The federal agency is shuffling around its programs to streamline management and promote international scientific collaboration.

2 Comments

image: Robot Legs Obey Brain

Robot Legs Obey Brain

By | September 7, 2012

A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.

1 Comment

image: Funding Cuts Threaten Big Data

Funding Cuts Threaten Big Data

By | September 5, 2012

Reduced support from the US National Library of Medicine threatens to shut down five popular biological databases.

0 Comments

image: Epigenetic Drug Improves Cholesterol Levels

Epigenetic Drug Improves Cholesterol Levels

By | August 28, 2012

Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.

1 Comment

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. March for Science: Dispatches from Washington, DC
AAAS